CAS.NO: 844439-96-9

Insulin Degludec, diabetes API, is an ultra-long-acting insulin analogue. Previous studies have shown that it has an ultra-long-term hypoglycemic effect and can reduce the risk of hypoglycemia. 

Insulin Degludec Specifications

Product Name Insulin Degludec

Packing Specification 10g/100g/500g

Appearances White or off-white powder

Activity: NLT 10Unit/mg NLT 10Unit/mg

Content: 95.0%~105.0% 95.0%~105.0%

Bacterial Endotoxin Less than 10 EU/mg

Residual HCP NMT 10ng/mg

Residual Exogenous DNA NMT 10ng/dose

Macromolecular Potein NMT 0.4%

HPLC Purity ＞99.0%

Storage Conditions -15℃ below, protected from light, sealed

Insulin Degludec Recommended Method

Insulin degludec injection easy dissolved in acidic (pH